Alector (STU:0Z2) Total Operating Expense : €217.31 Mil (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Alector Total Operating Expense?

Alector's Total Operating Expense for the three months ended in Mar. 2025 was €44.74 Mil. Alector's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was €217.31 Mil.

Alector Total Operating Expense Historical Data

The historical data trend for Alector's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alector Total Operating Expense Chart

Alector Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Operating Expense

Get a 7-Day Free Trial

177.78

216.33

256.25

228.15

234.51

Alector Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Operating Expense	Get a 7-Day Free Trial															54.83	56.38	57.46	58.72	44.74

Alector Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €217.31 Mil.

Alector Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Alector's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Alector Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alector Inc (STU:0Z2) » Definitions » Total Operating Expense

Comparable Companies

Traded in Other Exchanges

ALEC:USA

Address

131 Oyster Point Boulevard, Suite 600, South San Francisco, CA, USA, 94080

Website

https://www.alector.com

Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

Alector Headlines

No Headlines